Pre-Operative Study of PF-4691502 With Letrozole Compared To Letrozole Alone In Patients With Early Breast Cancer
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Early Breast Cancer (Phase 2)|Advanced Breast Cancer (Phase 1b)
Interventions: DRUG: PF-04691502|DRUG: PF-04691502 in combination with Letrozole|DRUG: Letrozole
Sponsor: Pfizer